Ribobay Pharma and Cytiva Collaborate to Revolutionize Oligonucleotide Manufacturing

    Ribobay Pharma, a prominent Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO), in conjuncti...

May 09, 2024 | Thursday | News
AbbVie Pledges €150 Million for State-of-the-Art R&D Facility in Germany, Fostering Innovation

New state-of-the-art research and development (R&D) facility at Ludwigshafen to expand discovery and development of new medicines across core therape...

May 01, 2024 | Wednesday | News
SK pharmteco Partners with Ferring Pharmaceuticals to Scale Up Production of ADSTILADRIN® Gene Therapy

Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...

April 18, 2024 | Thursday | News
INTERPHEX24: Industry Leaders Redefine Decontamination Protocols for Sterile Product Manufacturing

  The quest for efficiency without compromising safety and compliance is paramount. This was the central theme of the panel discussion titled "Reimag...

April 17, 2024 | Wednesday | Expert Opinion
Industry Titans Illuminate Path to Pharmaceutical Innovation at INTERPHEX 2024

Industry pioneers Maria Batalha, Kevin J. Bittorf, Matthew Mollan, and John Nadzam took center stage at INTERPHEX 2024 to share their expertise and insight...

April 17, 2024 | Wednesday | Expert Opinion
Blue Wolf Capital Partners to Acquire Seven European Manufacturing and Development Facilities from Recipharm

    The facilities, located in Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France...

April 03, 2024 | Wednesday | News
Bora Pharmaceuticals Completes Acquisition of Upsher-Smith Laboratories, Fortifying Presence in U.S. Generics Market

Bora Pharmaceuticals Co., Ltd.  announced that it has completed the acquisition of Upsher-Smith  Laboratories, LLC. (“Upsher-Smith”),...

April 02, 2024 | Tuesday | News
Abzena's $5 Million Investment Boosts Bristol Facility's Bioconjugation Capabilities and Enhances Operational Efficiency

 The $5 million investment in expanded laboratory space, new equipment, and facility upgrades, builds upon the site’s existing bioconjugation ca...

March 28, 2024 | Thursday | News
SCHOTT Pharma to Establish State-of-the-Art Facility in Wilson, North Carolina, Bolstering U.S. Pharmaceutical Supply Chain

   SCHOTT Pharma announces plans to solidify its footprint in the United States with the establishment of a cutting-edge facility in Wilson, Nor...

March 19, 2024 | Tuesday | News
Catalent Publishes Fifth Annual Corporate Responsibility Report, Demonstrating Commitment to Sustainability and Social Impact

    One of the notable achievements in fiscal 2023 was Catalent's robust efforts to mitigate its environmental impact and combat climate ...

March 08, 2024 | Friday | News
Hovione Adopts Micellar Tech for Greener API Production

Hovione has entered into a license agreement with Dragonfly Technologies, Inc. to offer its customers the breakthrough micellar technology developed by...

March 08, 2024 | Friday | News
CordenPharma Boosts Peptide API Production with New GMP Facilities in Frankfurt for Early Clinical Phase Manufacturing

After an initial expansion of the CordenPharma Frankfurt site for non-GMP manufacturing in 2020, and because of sustained success and exemplary perfor...

March 07, 2024 | Thursday | News
CoreRx, Inc. Set to Acquire Societal CDMO, Bolstering CDMO Sector Capabilities

This strategic acquisition marks a pivotal step towards creating a combined entity with expanded capabilities and a robust service offering that spans from...

February 29, 2024 | Thursday | News
Vetter Pioneers Market Launch of Eight Innovative Drug Products in 2023

Vetter, a globally recognized contract development and manufacturing organization (CDMO), proudly announces the successful market introduction of eight cus...

February 14, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in